Clinical Trials · NCT02648204
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,201
- Start date
- Jan 2016
- Locations
- 209 sites, 17 countries
- Primary endpoint
- Change in HbA1c